Penile Implants

Penile Implants Market Outlook

The global penile implants market is projected to reach USD 1.5 billion by 2035, growing at a CAGR of 5.9% during the forecast period from 2025 to 2035. This growth is driven by several factors, including the rising prevalence of erectile dysfunction (ED) among the aging population, increasing awareness of penile implants as a treatment option, and advancements in surgical techniques and technologies. Moreover, changing societal attitudes towards sexual health, along with significant investments in healthcare infrastructure, further contribute to the market’s expansion. Additionally, the growing demand for minimally invasive procedures is expected to create more opportunities for penile implants, making them more accessible to patients. As a result, the market is going through transformative changes that accommodate both patient needs and technological innovations.

Growth Factor of the Market

Several growth factors are driving the penile implants market to new heights. Primarily, the increasing incidence of erectile dysfunction, which affects a substantial proportion of the male population, especially those over 40 years of age, has amplified the demand for effective treatment options. Furthermore, the rising prevalence of underlying health conditions such as diabetes, cardiovascular diseases, and psychological disorders that contribute to erectile dysfunction is pushing patients towards surgical interventions like penile implants. The acceptance of these devices, alongside a growing body of clinical evidence supporting their efficacy, is also contributing to market growth. Moreover, advancements in materials and technology have enhanced the comfort and functionality of penile implants, making them a more appealing option for patients. Lastly, healthcare providers are increasingly advocating for surgical interventions as viable long-term solutions to ED, promoting wider adoption and utilization across various demographics.

Key Highlights of the Market

• The global penile implants market is expected to grow at a CAGR of 5.9% from 2025 to 2035.
• Increasing awareness among patients and healthcare providers regarding treatment options is driving market growth.
• Technological advancements are leading to safer and more effective penile implant solutions.
• There is a growing focus on minimally invasive surgical procedures, resulting in higher patient satisfaction.
• North America currently holds the largest market share due to a higher prevalence of erectile dysfunction.

By Product Type

Semi-Rigid Rods:

Semi-rigid rods are one of the oldest forms of penile implants available on the market. They consist of bendable rods that maintain a constant state of rigidity, allowing for easier positioning of the penis for sexual intercourse. The simplicity of this design and its lower cost compared to other types of implants contribute to its continued popularity among patients. However, while they offer a reliable solution for erectile dysfunction, semi-rigid rods may not provide the natural feel or spontaneity that inflatable implants do. As such, they tend to be favored by patients who prioritize a straightforward and proven solution over aesthetic flexibility.

Inflatable Implants:

Inflatable implants are increasingly becoming the preferred choice for many patients facing erectile dysfunction. These devices consist of inflatable cylinders implanted within the penis, a pump located in the scrotum, and a fluid reservoir usually placed in the abdomen. When the patient wishes to achieve an erection, they can simply activate the pump to inflate the cylinders, which provides a more natural sensation and appearance when compared to other types of implants. The versatility and functionality of inflatable implants are significant advantages, making them suitable for a broader range of patients, including those who prioritize discretion and ease of use in their treatment options.

Malleable Implants:

Malleable implants, also known as bendable implants, are similar to semi-rigid rods in that they maintain a consistent level of rigidity. However, they offer the added benefit of being adjustable; healthcare providers can position the penis at the desired angle for sexual activity. These implants are particularly advantageous for patients who may not wish to engage in sexual activity spontaneously, as they allow for manual adjustment to achieve an erection. While offering reliability and simplicity, malleable implants may not provide the same level of aesthetic appeal and naturalness as inflatable options, but they serve as a solid choice for many men seeking treatment for erectile dysfunction.

Positionable Prostheses:

Positionable prostheses represent an innovative approach within the penile implant market. These implants are designed to allow patients to adjust the position of their penis manually, offering flexibility similar to both inflatable and malleable implants. The key advantage of positionable prostheses lies in their ability to provide a more personalized experience, accommodating individual preferences for sexual activity. As patients become more informed about their treatment options, the demand for customizable solutions is expected to rise, and positionable prostheses are well-positioned to meet this need effectively, ensuring patient satisfaction and improved quality of life.

Self-contained Unit Prostheses:

Self-contained unit prostheses are a newer segment in the penile implant market, integrating all components into a single unit for easier implantation and use. These devices are engineered for simplicity and reduced surgical time, providing a seamless solution for erectile dysfunction. Patients find self-contained units appealing due to their user-friendly design and lower complication rates. As healthcare systems move towards patient-centered care, the demand for self-contained prostheses is anticipated to grow, driven by their advantages in terms of ease of use and minimal invasive procedures, which align with evolving patient expectations in medical treatments.

By Application

Erectile Dysfunction:

Erectile dysfunction (ED) remains the primary application driving the demand for penile implants globally. This condition affects millions of men and can stem from various factors, including aging, medical conditions such as diabetes and hypertension, psychological issues, and lifestyle choices. As awareness of ED grows alongside societal acceptance of discussing sexual health, more men are seeking effective and long-lasting treatment options. Penile implants are often considered a last resort after other treatment modalities, like oral medications or vacuum devices, have failed. The increasing prevalence of ED, particularly among an aging population, underscores the need for innovative solutions in this segment.

Peyronie's Disease:

Peyronie's Disease, characterized by the development of fibrous scar tissue within the penis, can lead to curvature and painful erections, significantly affecting a man's sexual function and quality of life. The surgical intervention through penile implants has emerged as a critical treatment option for patients suffering from this condition, especially when conservative treatments are ineffective. The rise in awareness of Peyronie's Disease and the successful outcomes associated with penile implant surgery contribute to expanding this segment of the market. The growing understanding of the psychological impacts of Peyronie's Disease also drives patients to seek comprehensive solutions, further propelling the uptake of implants in this category.

Penile Cancer:

Penile cancer, though relatively rare, presents unique challenges when it comes to treatment and management. Patients may face surgical options such as partial or total penectomy, which can drastically affect sexual function. In such cases, penile implants can play a vital role in restoring sexual function and enhancing the quality of life for survivors. As healthcare providers increasingly acknowledge the importance of sexual health as part of cancer care, the demand for penile implants in this application is anticipated to grow. Additionally, the increasing focus on survivorship care and the psychological aspects of cancer recovery highlight the importance of addressing sexual dysfunction as part of comprehensive treatment plans.

Penile Trauma:

Penile trauma can result from various incidents, including accidents, surgical complications, or even violent acts. Such injuries often lead to significant physical and psychological challenges, including erectile dysfunction and changes in penile structure. The installation of penile implants offers a reconstructive solution that restores function and appearance, enabling patients to regain confidence and improve their sexual health. The growing awareness of trauma-related conditions and the acceptance of surgical interventions as viable treatment options are expected to drive the demand within this application segment. As healthcare practitioners become more proactive in addressing the needs of trauma patients, the market for penile implants in this category will likely experience growth.

Others:

This category encompasses various applications not explicitly covered, such as congenital penile abnormalities or other specific conditions leading to erectile dysfunction. Patients with these unique challenges benefit significantly from tailored solutions like penile implants. The continuous advancement in medical technologies has broadened options for patients facing diverse issues, thereby increasing the overall uptake of penile implants. As patient awareness grows and healthcare providers expand treatment offerings, this segment is expected to see a noteworthy increase, contributing to the overall market growth.

By Distribution Channel

Hospitals:

Hospitals play a pivotal role in the distribution of penile implants, serving as the primary setting for surgical procedures. With advanced surgical facilities and experienced urologists, hospitals are equipped to provide comprehensive care for patients undergoing penile implant surgeries. The institutional environment fosters trust, ensuring patients feel secure in their treatment choices. Moreover, hospitals often have established partnerships with manufacturers, facilitating easier access to the latest implant technologies. As the prevalence of erectile dysfunction continues to rise, the demand for surgical procedures in hospitals is also expected to increase, promoting growth within this distribution channel.

Specialty Clinics:

Specialty clinics focused on sexual health and urology have emerged as significant channels for distributing penile implants. These clinics often provide a more personalized experience for patients, offering specialized consultations and tailored treatment plans. The concentrated expertise in these clinics enables healthcare providers to address complex cases effectively and ensures patients receive the best possible care. Additionally, the rising awareness among patients regarding sexual health issues has led to increased visits to specialty clinics, further solidifying their position within the market. As the demand for specialized treatment options increases, the role of specialty clinics in the penile implants market is expected to grow.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) have gained prominence as efficient alternatives to hospitals for minor surgical procedures, including penile implant surgeries. These centers offer the advantage of lower costs and shortened recovery times, making them an attractive option for patients seeking surgical correction for erectile dysfunction. The streamlined processes and focused care provided by ASCs also contribute to higher patient satisfaction rates. As healthcare systems increasingly embrace outpatient care and prioritize cost-effective surgical solutions, the demand for penile implant procedures in ambulatory surgical centers is anticipated to rise, reflecting a growing trend in the overall market.

Online Platform:

The advent of digital healthcare solutions has transformed various aspects of the penile implants market, particularly in terms of patient education and consultation services. Online platforms facilitate access to information about penile implants, enabling patients to understand their treatment options better. Moreover, many manufacturers and healthcare providers are now implementing telehealth services, allowing patients to consult with specialists from the comfort of their homes. This shift towards digital solutions has improved patient engagement while allowing providers to reach a broader audience. As the market evolves, the online distribution channel is expected to play an increasingly significant role, complementing traditional healthcare settings.

Retail Pharmacies:

Retail pharmacies offer an emerging distribution channel for penile implants, particularly for the ancillary products associated with them. While the surgical implants themselves typically require specialized medical settings for implantation, retail pharmacies can provide supportive products, such as vacuum devices and penile rehabilitation options. Furthermore, pharmacies often serve as accessible points for patient consultations, where healthcare professionals can offer guidance and advice on treatment options. As the market continues to grow, expanding the availability of related products through retail channels will likely enhance patient access to comprehensive care solutions.

By Material Type

Silicone:

Silicone is one of the most widely used materials in penile implants due to its biocompatibility and durability. This synthetic material is well-suited for medical applications, as it minimizes the risk of adverse reactions while providing a soft and natural feel. Silicone implants have been shown to be effective in restoring erectile function, and their resilience ensures longevity, making them a preferred choice for both patients and healthcare providers. As patient safety and comfort remain priorities in implant design, silicone is expected to retain its prominence in the penile implants market, offering reliable solutions for men facing erectile dysfunction.

Bioflex:

Bioflex is a newer material gaining traction in the penile implants market due to its unique properties that mimic natural tissue. This advanced biocompatible polymer offers flexibility and strength, which can enhance patient comfort and satisfaction post-implantation. The use of Bioflex technology also aims to reduce complications associated with traditional materials, providing better outcomes for patients. As medical advancements continue to evolve, the incorporation of Bioflex into penile implants presents an exciting opportunity for product innovation and increased efficacy, making it a vital segment within the material types.

Stainless Steel:

Stainless steel has traditionally been utilized in the construction of penile implants, particularly in malleable and semi-rigid designs. This material is favored for its strength and durability, providing a solid framework for penile prostheses. While stainless steel implants offer reliability and longevity, the rigidity may not provide the same level of comfort or natural feel as newer materials like silicone and Bioflex. As patients increasingly seek options that prioritize aesthetics and comfort, the demand for stainless steel implants may shift, leading to further innovations in material research to enhance user experience.

Coated Silicone:

Coated silicone implants represent an advanced iteration of traditional silicone implants, designed to enhance biocompatibility and reduce friction during use. The coatings typically involve materials that are engineered to minimize the risk of infection and improve the overall performance of the implants. By providing a smoother surface, coated silicone implants can enhance patient comfort significantly while reducing the potential for complications. As the focus on patient-centered design continues to rise, coated silicone implants are likely to gain traction in the market, meeting the demands for both efficacy and user satisfaction.

Polyurethane:

Polyurethane is another innovative material entering the penile implants market, known for its potential to enhance the biocompatibility and longevity of implant devices. This material is often used in conjunction with other materials to increase comfort and reduce the risk of infection. Polyurethane-coated implants may offer additional advantages, such as improved integration with surrounding tissues, leading to better surgical outcomes. As research continues to validate the benefits of polyurethane in medical applications, its usage in penile implants is expected to expand, contributing to the overall evolution of treatment options available to patients.

By Region

The penile implants market exhibits varying trends across different regions, influenced by factors such as healthcare infrastructure, cultural attitudes towards sexual health, and prevalence rates of conditions like erectile dysfunction. North America currently holds the largest market share, estimated at around 45% of the global market. This can be attributed to the high prevalence of erectile dysfunction, substantial healthcare spending, and a robust network of healthcare providers specializing in sexual health. Moreover, North America is witnessing a CAGR of approximately 6.5%, driven by increasing awareness and acceptance of surgical solutions to sexual health issues among the aging population.

In Europe, the penile implants market is projected to grow significantly, capturing around 30% of the global market share. The region benefits from advanced medical technologies and a high standard of healthcare services, fostering a favorable environment for the adoption of penile implants. Countries such as Germany and the UK are at the forefront of adopting innovative solutions for erectile dysfunction. The Asia Pacific region is also experiencing notable growth, expected to reach a market share of around 15% by 2035, driven by the rising incidence of erectile dysfunction and increasing healthcare investments in countries like India and China.

Opportunities

The penile implants market presents numerous opportunities for growth, particularly driven by advancements in technology and evolving patient needs. One of the key opportunities lies in the continuous innovation of implant materials and designs that prioritize patient comfort, ease of use, and durability. As research focuses on developing bio-compatible materials that mimic natural tissue, manufacturers can introduce products that cater to the demands of a more informed and discerning patient base. Moreover, as society becomes more open to discussing sexual health issues, healthcare providers can leverage this trend by increasing awareness and education about available treatment options, ultimately driving higher patient engagement and uptake of penile implants.

Furthermore, expanding access to healthcare services, especially in emerging economies, presents a significant opportunity for market growth. As healthcare infrastructure improves and more men seek treatment for erectile dysfunction, the demand for penile implants is likely to rise. Manufacturers and healthcare providers can collaborate to raise awareness in underrepresented areas, ensuring patients have access to the latest medical advancements. Additionally, the growing trend of personalized medicine presents avenues for tailored treatment options, allowing healthcare providers to offer customized solutions that meet the unique needs of individual patients, thereby enhancing satisfaction and outcomes in the penile implants market.

Threats

Despite the promising growth potential in the penile implants market, several threats could hinder its progress. One of the primary concerns is the increasing scrutiny and regulatory oversight surrounding medical devices. As governments and health agencies adopt stricter regulations to ensure patient safety, manufacturers may face challenges in bringing new products to market. The lengthy approval processes and associated costs can impede innovation and delay the availability of advanced penile implant solutions. Additionally, the rising competition from alternative treatment options, such as oral medications and vacuum devices, poses a threat to the traditional penile implant market, as patients may prefer less invasive solutions that require minimal procedure involvement.

Another significant challenge comes from the stigma associated with erectile dysfunction and sexual health issues. Many men may be reluctant to seek treatment due to societal perceptions or feelings of embarrassment, leading to underdiagnosis and undertreatment of erectile dysfunction. This psychological barrier can impede market growth, as potential patients may avoid exploring surgical options like penile implants. Furthermore, the availability of misleading information on the internet regarding ED treatments can exacerbate confusion, preventing patients from making informed decisions about their health. Addressing these issues will be crucial for stakeholders to ensure optimal market development and acceptance of penile implants.

Competitor Outlook

• Boston Scientific Corporation
• Coloplast A/S
• C.R. Bard, Inc. (BD)
• American Medical Systems, Inc.
• Endo International plc
• Promedon S.A.
• Zephyr Surgical Implants
• UroLift System
• Medtronic plc
• Silimed
• Surgical Solutions, LLC
• Titan Medical, Inc.
• InControl Medical, LLC
• DirecTech, Inc.
• Osbon Medical Systems, Inc.

The competitive landscape of the penile implants market is characterized by a mix of established companies and emerging players striving to gain market share. Major players, such as Boston Scientific Corporation and Coloplast A/S, dominate the market with extensive portfolios of innovative products and a strong global presence. These companies focus heavily on research and development to introduce advanced penile implant technologies, such as inflatable and self-contained prostheses, that enhance patient outcomes and satisfaction. Additionally, their robust distribution networks and collaborations with healthcare providers allow them to effectively reach a large patient base and maintain their competitive edge.

Emerging competitors in the market are also making strides by focusing on niche applications and specific patient needs, such as treating Peyronie's Disease or providing customizable solutions. Companies like Promedon S.A. and Zephyr Surgical Implants are gaining traction by introducing innovative products that feature advanced materials and designs, catering to the evolving demands of patients and healthcare providers alike. As the market expands, these emerging players have the potential to challenge established companies by introducing differentiated products that meet the specific preferences of patients, driving further competition and innovation.

In conclusion, the penile implants market is poised for significant growth in the coming years, driven by the rising prevalence of erectile dysfunction and advancements in medical technology. Key players are likely to continue investing in research and development to enhance product offerings and optimize patient care. The competitive landscape will evolve as new entrants emerge and existing companies adapt to changing patient needs, emphasizing the importance of staying ahead of trends in this dynamic market. By understanding the competitive environment and fostering collaboration with healthcare stakeholders, companies can position themselves for success and contribute to the ongoing advancement of penile implant solutions.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Silimed
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Coloplast A/S
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Promedon S.A.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 UroLift System
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 DirecTech, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Titan Medical, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 C.R. Bard, Inc. (BD)
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Endo International plc
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 InControl Medical, LLC
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Surgical Solutions, LLC
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Zephyr Surgical Implants
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Osbon Medical Systems, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 American Medical Systems, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Penile Implants Market, By Application
    • 6.1.1 Erectile Dysfunction
    • 6.1.2 Peyronie's Disease
    • 6.1.3 Penile Cancer
    • 6.1.4 Penile Trauma
    • 6.1.5 Others
  • 6.2 Penile Implants Market, By Product Type
    • 6.2.1 Semi-Rigid Rods
    • 6.2.2 Inflatable Implants
    • 6.2.3 Malleable Implants
    • 6.2.4 Positionable Prostheses
    • 6.2.5 Self-contained Unit Prostheses
  • 6.3 Penile Implants Market, By Material Type
    • 6.3.1 Silicone
    • 6.3.2 Bioflex
    • 6.3.3 Stainless Steel
    • 6.3.4 Coated Silicone
    • 6.3.5 Polyurethane
  • 6.4 Penile Implants Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Platform
    • 6.4.5 Retail Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Penile Implants Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Penile Implants market is categorized based on

By Product Type

• Semi-Rigid Rods
• Inflatable Implants
• Malleable Implants
• Positionable Prostheses
• Self-contained Unit Prostheses

By Application

• Erectile Dysfunction
• Peyronie's Disease
• Penile Cancer
• Penile Trauma
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Platform
• Retail Pharmacies

By Material Type

• Silicone
• Bioflex
• Stainless Steel
• Coated Silicone
• Polyurethane

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Coloplast A/S
• C.R. Bard, Inc. (BD)
• American Medical Systems, Inc.
• Endo International plc
• Promedon S.A.
• Zephyr Surgical Implants
• UroLift System
• Medtronic plc
• Silimed
• Surgical Solutions, LLC
• Titan Medical, Inc.
• InControl Medical, LLC
• DirecTech, Inc.
• Osbon Medical Systems, Inc.